A new sensing layer for biological detection.

ISBRG non-invasively analyzes biological changes within seconds, revealing early-stage viral infection and disease.

PLATFORM

SpotLight™

Non-invasive, 30-second optical biosignature screening.

LEARN MORE → 
MODEL

Thermocline AI

Designed to interpret biological signal data.

LEARN MORE →

Selected as one of ten companies worldwide for the 2026 Mayo Clinic and ASU Health Care Accelerator, for the SpotLight-C™ cancer platform.

Cancer Screening

Invited to the National Security Commission on Emerging Biotechnology, Arizona Summit, to present the SpotLight™ biodefense platform.

Biodefense

Experienced leadership from aerospace, pharmaceutical, diagnostics, intelligence and academic medicine.

Advisory Board

ADVISORY BOARD →

News

Biological War and Cancer: What We Now Know, What We Need, and What AI Is Doing About It

RECENT ISBRG ARTICLE →